Chinese-made innovative drugs hit 100-billion-yuan market scale
Chinese authorities have approved 113 domestically developed innovative drugs for market entry since 2021, with the scale of the market now at 100 billion yuan (US$13.89 billion), a conference in Shanghai revealed on Saturday.
According to a report released during the ongoing China Pharmaceutical Industry Development Conference, 165 innovative devices have been approved in the medical device sector during China's 14th Five-Year Plan (2021-2025) period. Many of these devices incorporate cutting-edge technologies, including deep learning, magnetic levitation, and magnetic resonance monitoring.
The report also notes significant progress in China's industrialization of biological drugs, in its advancement of intelligent manufacturing, and in the green development of the active pharmaceutical ingredient industry.
The conference kicked off on Saturday and lasts until November 18.
In Case You Missed It...

![[Hai Streets] A Walk on Fuxing Island, From Shipyard Cranes to a Riverside Garden](https://obj.shine.cn/files/2026/11/21/a1ca0301-bee2-48a3-a96f-4068c113d5a9_0.png)

![[ChinaMaxxing] The Weather We're Having Now Is Called Xiaoxue](https://obj.shine.cn/files/2026/11/20/29057db6-0ed4-4e29-acb7-228e358d27fa_0.png)
Popular Reads

Global Tech Selloff Snares Chinese Stocks Amid Doubts About the AI Boom

Shanghai, Singapore Ink 16 Deals, Advancing Cross-border Finance, Innovation and Cultural Ties

Viral Beijing Photo Brings Couple Back to Tie the Knot

